WP
RAIN

Woodline Partners’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Woodline Partners’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-119,700
Closed -$1.05M – 797
2023
Q1 		$1.05M Sell
119,700
-134,928
-53% -$1.25M 0.01% 470
2022
Q4 		$2.04M Buy
254,628
+134,928
+113% +$847K 0.03% 473
2022
Q3 		$584K Hold
119,700
– – 0.01% 584
2022
Q2 		$666K Hold
119,700
– – 0.01% 550
2022
Q1 		$607K Hold
119,700
– – 0.01% 511
2021
Q4 		$1.54M Hold
119,700
– – 0.02% 450
2021
Q3 		$1.79M Hold
119,700
– – 0.03% 432
2021
Q2 		$1.86M Buy
+119,700
New +$2.1M 0.03% 370

Other funds holding RAIN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Woodline Partners's RAIN Position: Q2 2023 in Review

Woodline Partners sold out of Rain Oncology Inc. Common Stock (RAIN) in Q2 2023, closing a stake of 119,700 shares — an estimated $1.05M sold.

Woodline Partners first reported a position in RAIN in Q2 2021 and held it in 8 quarters. The position peaked at $2.04M in Q4 2022. 62 funds tracked by Wall St. Rank hold RAIN as of Q2 2023.

  • Woodline Partners reported no remaining Rain Oncology Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Woodline Partners sold 119,700 Rain Oncology Inc. Common Stock shares in Q2 2023, an estimated $1.05M.
  • Woodline Partners first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Woodline Partners's Rain Oncology Inc. Common Stock position peaked at $2.04M in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q2 2023.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.